Polymeric nanoparticles as original theranostic approach for alzheimer‟s disease
type: Dataset
contact point: Organization
  fn: CCSD
keyword: polyalkyl-cyanocrylate-nanoparticles
keyword: sdvmheplife-sciences-q-biohuman-health-and-pathology
keyword: nanoparticules-de-polycyanoacrylate-dalkyle
keyword: alzheimers-disease
keyword: sdvsalife-sciences-q-bioagricultural-sciences
keyword: barriere-hemato-encephalique
keyword: theses
keyword: peptide--amyloide
keyword: -amyloid-peptide
keyword: blood-brain-barrier
keyword: infoeu-reposemanticsdoctoralthesis
landing page: https://theses.hal.science/tel-00692581
description: The proof of concept of an original nanotechnology-based theranostic approach for Alzheimer‟s disease has been explored. Novel fluorescently tagged nanoparticles have been designed and employed for internalization and transcytosis studies across a recently developed human in vitro blood-brain barrier model. A small library of polymeric nanoparticles have been designed and their ability to capture the Amyloid β1-42 peptide, considered one of the causes of the Alzheimer‟s disease, has been investigated and quantified using an on purpose designed method.
identifier: NNT: 2012PA114801
issued: 2026-05-20T09:42:05.415311
language: en
modified: 2026-05-20T09:42:05.415317

test_moissonnage_selune
type: Agent

Polymeric nanoparticles as original theranostic approach for alzheimer‟s disease
type: Distribution
access URL: https://theses.hal.science/tel-00692581
format: HTML
issued: 2026-05-20T09:42:05.423800
modified: 2026-05-20T09:42:05.374128